Monopar Therapeutics (MNPR) Q2 2026 Earnings

7MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Next
-0.84
-0.67
-0.51
-0.35

Details

Expected EPS
-0.835417
Actual EPS
N/A
Surprise EPS
0.84
Surprise Percent
+100%

Description

Monopar Therapeutics (MNPR) will report earnings of for Q2 2026 on May 07, 2026.

0 Comments

Share your thoughts